Martinaityte Ieva, Jorde Rolf, Emaus Nina, Eggen Anne Elise, Joakimsen Ragnar Martin, Kamycheva Elena
Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway.
PLoS One. 2017 Mar 2;12(3):e0173045. doi: 10.1371/journal.pone.0173045. eCollection 2017.
Bone mineral density (BMD) is determined by bone remodeling processes regulated by endocrine, autocrine and genetic mechanisms. Thus, some studies have reported that BMD is associated with single nucleotide polymorphisms (SNPs) associated with vitamin D receptor (VDR), serum 25(OH)D levels and estrogen receptor 1 (ESR1), but without consensus. Therefore, we aimed to map and compare the risk genotypes for forearm and total hip low BMD.
Data were derived from a population-based study in northern Norway; the Tromsø Study. Distal forearm BMD was measured with a single x-ray absorptiometric device, while total hip BMD was measured with a dual-energy x-ray absorptiometric device. There were 7,317 and 4,082 successful analyses of distal forearm and total hip BMD, respectively, and at least one SNP of interest. We evaluated plausible BMD modulating factors and associations of BMD and SNPs related to vitamin D metabolism (FokI, Cdx2, BsmI, rs2298850, rs10741657, rs3794060, rs6013897), ApaI-BsmI-TaqI haplotypes and ESR1 SNP rs4870044.
Age, BMI, physical activity and smoking were significantly associated with BMD. In a linear regression model with adjustment for age and gender and with the major homozygote as reference, rs6013897 had a standardized beta coefficient (β) of -0.031 (P = 0.024) for total hip BMD. β for ESR1 SNP rs4870044 was -0.016 (P = 0.036) for forearm BMD and -0.034 (P = 0.015) for total hip BMD. The other SNPs nor serum 25(OH)D were significantly associated with BMD.
Both forearm and total hip BMD were associated with ESR1 SNP rs4870044. Of the vitamin D-related genes, only CYP24A1 gene rs6013897 was associated with total hip BMD, but the association was weak and needs confirmation in other studies. Serum 25(OH)D was not associated with BMD in our population, probably due to the generally sufficient vitamin D levels in the population.
骨矿物质密度(BMD)由内分泌、自分泌和遗传机制调节的骨重塑过程决定。因此,一些研究报告称BMD与维生素D受体(VDR)、血清25(OH)D水平和雌激素受体1(ESR1)相关的单核苷酸多态性(SNP)有关,但尚无定论。因此,我们旨在绘制并比较前臂和全髋部低骨密度的风险基因型。
数据来源于挪威北部的一项基于人群的研究;特罗姆瑟研究。用单能X线吸收仪测量远端前臂骨密度,用双能X线吸收仪测量全髋部骨密度。分别对7317例和4082例远端前臂和全髋部骨密度进行了成功分析,且至少有一个感兴趣的SNP。我们评估了合理的骨密度调节因素以及骨密度与维生素D代谢相关的SNP(FokI、Cdx2、BsmI、rs2298850、rs10741657、rs3794060、rs6013897)、ApaI - BsmI - TaqI单倍型和ESR1 SNP rs4870044之间的关联。
年龄、体重指数、身体活动和吸烟与骨密度显著相关。在一个调整了年龄和性别的线性回归模型中,以主要纯合子为参照,rs6013897对全髋部骨密度的标准化β系数(β)为 - 0.031(P = 0.024)。ESR1 SNP rs4870044对前臂骨密度的β为 - 0.016(P = 0.036),对全髋部骨密度的β为 - 0.034(P = 0.015)。其他SNP以及血清25(OH)D与骨密度均无显著关联。
前臂和全髋部骨密度均与ESR1 SNP rs4870044有关。在与维生素D相关的基因中,只有CYP24A1基因rs6013897与全髋部骨密度有关,但这种关联较弱,需要其他研究加以证实。在我们的人群中,血清25(OH)D与骨密度无关,这可能是由于该人群中维生素D水平总体充足。